Koers Radient Technologies Inc Toronto S.E.
Aandelen
CA75034P1062
Farmaceutische producten
Omzet 2021 | 2,49 mln. 1,81 mln. 1,67 mln. | Omzet 2022 | 3,62 mln. 2,63 mln. 2,44 mln. | Marktkapitalisatie | 29,2 mln. 21,2 mln. 19,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -42 mln. -30,49 mln. -28,26 mln. | Nettowinst (verlies) 2022 | -12 mln. -8,71 mln. -8,07 mln. | EV/omzet 2021 | 21,6 x |
Nettoschuld 2021 | 11,44 mln. 8,31 mln. 7,7 mln. | Nettoschuld 2022 | 13,67 mln. 9,93 mln. 9,2 mln. | EV/omzet 2022 | 11,8 x |
K/w-verhouding 2021 |
-0,85
x | K/w-verhouding 2022 |
-1,93
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 99,98% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Splinter
FOU | Founder | - | 12-06-01 |
Director of Finance/CFO | - | 22-05-14 | |
Zachary Riauka
COO | Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | - | 22-05-14 | |
Steven Splinter
FOU | Founder | - | 12-06-01 |
Jan Petzel
BRD | Director/Board Member | 51 | 23-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,50% | 6,2 mld. | |
-22,89% | 4,1 mld. | |
+9,36% | 3,41 mld. | |
-19,39% | 2,83 mld. | |
-11,05% | 2,29 mld. | |
+45,24% | 1,93 mld. | |
+46,81% | 1,51 mld. | |
-7,51% | 1,52 mld. | |
-18,04% | 1,49 mld. |